AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23461916 — intervention group
Group type: EXPERIMENTAL
Intervention: Driven gait orthosis (Lokomat)
Number of subjects: 14
Study 23461916 — intervention group
Group type: COMPARATOR
Intervention: Gait training along a rail inside a hydrotherapy tank
Number of subjects: 14
Study 20522698 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically integrated e‐learning EBM course
Number of subjects: 237
Study 20522698 — intervention group
Group type: COMPARATOR
Intervention: Lecture‐based course
Number of subjects: 237
Study 18318455 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (2 mg)
Number of subjects: 0
Study 18318455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16824242 — intervention group
Group type: EXPERIMENTAL
Intervention: MCT/LCT‐propofol
Number of subjects: 120
Study 16824242 — intervention group
Group type: COMPARATOR
Intervention: LCT‐propofol
Number of subjects: 120
Study 12796139 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine (8 mg)
Number of subjects: 0
Study 12796139 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10853456 — intervention group
Group type: EXPERIMENTAL
Intervention: New endocrine agents for receptor-positive patients
Number of subjects: 0
Study 10853456 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-agent chemotherapy
Number of subjects: 0
Study 10853456 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical trials
Number of subjects: 0
Study 8771302 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostheses oriented in a perpendicular position with respect to the ventricular septum
Number of subjects: 90
Study 8771302 — intervention group
Group type: COMPARATOR
Intervention: Prostheses oriented in a parallel position with respect to the ventricular septum
Number of subjects: 90
Study 8771302 — intervention group
Group type: EXPERIMENTAL
Intervention: Both orientations
Number of subjects: 90
Study 1617601 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder plastic credit card
Number of subjects: 220
Study 1617601 — intervention group
Group type: COMPARATOR
Intervention: Traditional encouragement/reminders (control group)
Number of subjects: 220
Study 6383779 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (Spofa)
Number of subjects: 23
Study 6383779 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (Diluran Spofa)
Number of subjects: 23
Study 6383779 — intervention group
Group type: COMPARATOR
Intervention: Control (before therapy)
Number of subjects: 23
Study 31063024 — intervention group
Group type: EXPERIMENTAL
Intervention: Edmonton Symptom Assessment System (ESAS)
Number of subjects: 386
Study 31063024 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life at the end of life (QUAL‐E)
Number of subjects: 386
Study 31063024 — intervention group
Group type: EXPERIMENTAL
Intervention: Correspondence between ESAS and QUAL‐E
Number of subjects: 386
Study 31063024 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain and/or tiredness
Number of subjects: 386
Study 31063024 — intervention group
Group type: EXPERIMENTAL
Intervention: Appetite
Number of subjects: 386
Study 31063024 — intervention group
Group type: EXPERIMENTAL
Intervention: Probability of rating a symptom as most severe and most bothersome
Number of subjects: 386
Study 29853984 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking on a treadmill at a regular speed of 5 km/h
Number of subjects: 16
Study 26743397 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutraceutical diet (ND group)
Number of subjects: 30
Study 26743397 — intervention group
Group type: COMPARATOR
Intervention: Standard diet (SD group)
Number of subjects: 30
Study 24434584 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched biscuits+enriched juice (8g β‐glucan)
Number of subjects: 30
Study 24434584 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched biscuits+juice (4g β‐glucan)
Number of subjects: 30
Study 24434584 — intervention group
Group type: EXPERIMENTAL
Intervention: Biscuits+enriched juice (4g β‐glucan)
Number of subjects: 30
Study 24434584 — intervention group
Group type: COMPARATOR
Intervention: Biscuits+juice (0g β‐glucan)
Number of subjects: 30
Study 23234087 — intervention group
Group type: EXPERIMENTAL
Intervention: Active observation of dance therapy (30 min. live session)
Number of subjects: 100
Study 23234087 — intervention group
Group type: COMPARATOR
Intervention: Passive listening to pre-recorded music (30 min.)
Number of subjects: 100
Study 19572858 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact mapping
Number of subjects: 40
Study 19572858 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncontact mapping
Number of subjects: 40
Study 17212718 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunate S/D
Number of subjects: 56
Study 17212718 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic regimen with Immunate S/D
Number of subjects: 56
Study 17212718 — intervention group
Group type: COMPARATOR
Intervention: Immunate
Number of subjects: 56
Study 16097636 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep inspiration breath‐hold SPECT (BrST)
Number of subjects: 15
Study 16097636 — intervention group
Group type: COMPARATOR
Intervention: Conventional free breathing (FB) method
Number of subjects: 15
Study 12386350 — intervention group
Group type: EXPERIMENTAL
Intervention: NovaSure system
Number of subjects: 265
Study 12386350 — intervention group
Group type: COMPARATOR
Intervention: Wire loop resection and rollerball ablation
Number of subjects: 265
Study 9919039 — intervention group
Group type: EXPERIMENTAL
Intervention: Braun Oral‐B Interclean, model ID2
Number of subjects: 0
Study 9919039 — intervention group
Group type: COMPARATOR
Intervention: ADA‐approved waxed dental floss
Number of subjects: 0
Study 8571922 — intervention group
Group type: EXPERIMENTAL
Intervention: Danggui‐Nian‐Tong‐Tang (DGNTT)
Number of subjects: 0
Study 8571922 — intervention group
Group type: COMPARATOR
Intervention: Allopurinol
Number of subjects: 0
Study 8571922 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 0
Study 8571922 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro study in rats with DGNTT
Number of subjects: 0
Study 2210795 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation I (modified allergenic extract)
Number of subjects: 20
Study 2210795 — intervention group
Group type: COMPARATOR
Intervention: Preparation II (standard semi-depot extract)
Number of subjects: 20
Study 2210795 — intervention group
Group type: EXPERIMENTAL
Intervention: Both preparations
Number of subjects: 20
Study 530804 — intervention group
Group type: EXPERIMENTAL
Intervention: Blocked design
Number of subjects: 0
Study 530804 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised design
Number of subjects: 0
Study 31397126 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular-point pressure combined with personalized music therapy
Number of subjects: 1000
Study 27893933 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer and Treatment Distress (CTXD) measure before transplantation and at 100 days and 180 days after HCT
Number of subjects: 701
Study 27893933 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Outcomes Study Short Form‐36 (SF‐36) Mental Health subscale
Number of subjects: 701
Study 27893933 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretransplantation CTXD
Number of subjects: 701
Study 26498479 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer role play (RP)
Number of subjects: 69
Study 26498479 — intervention group
Group type: COMPARATOR
Intervention: Standardized patients (SP)
Number of subjects: 69
Study 23375209 — intervention group
Group type: EXPERIMENTAL
Intervention: Branched chain amino acids (BCAA)
Number of subjects: 1872
Study 23375209 — intervention group
Group type: EXPERIMENTAL
Intervention: Various metabolites
Number of subjects: 1872
Study 23375209 — intervention group
Group type: EXPERIMENTAL
Intervention: C4/Ci4, C3, C5 acylcarnitines
Number of subjects: 1872
Study 23375209 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acids
Number of subjects: 1872
Study 20978485 — intervention group
Group type: EXPERIMENTAL
Intervention: EMS practice (study group)
Number of subjects: 16
Study 20978485 — intervention group
Group type: COMPARATOR
Intervention: Control group (no EMS practice)
Number of subjects: 16
Study 19143016 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG laser + APF application
Number of subjects: 33
Study 19143016 — intervention group
Group type: COMPARATOR
Intervention: APF application (control group)
Number of subjects: 33
Study 17516149 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled insulin
Number of subjects: 299
Study 17516149 — intervention group
Group type: COMPARATOR
Intervention: Injectable insulin
Number of subjects: 299
Study 17516149 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment satisfaction
Number of subjects: 299
Study 17516149 — intervention group
Group type: EXPERIMENTAL
Intervention: Current treatment burden
Number of subjects: 299
Study 15026583 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg leflunomide
Number of subjects: 402
Study 15026583 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg leflunomide
Number of subjects: 402
Study 11787753 — intervention group
Group type: EXPERIMENTAL
Intervention: Agricultural work activities
Number of subjects: 1138
Study 11787753 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic variations in work involvement
Number of subjects: 1138
Study 9601481 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliant balloons (polyolefin copolymer)
Number of subjects: 200
Study 9601481 — intervention group
Group type: COMPARATOR
Intervention: Non-compliant balloons (polyethylene terapthelate)
Number of subjects: 200
Study 8022532 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine
Number of subjects: 23
Study 8022532 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 8022532 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal controls)
Number of subjects: 23
Study 2510283 — intervention group
Group type: EXPERIMENTAL
Intervention: Rioprostil, 300 micrograms b.d.
Number of subjects: 8
Study 2510283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 1106966 — intervention group
Group type: EXPERIMENTAL
Intervention: dextro-amphetamine
Number of subjects: 48
Study 1106966 — intervention group
Group type: EXPERIMENTAL
Intervention: methylphenidate
Number of subjects: 48
Study 1106966 — intervention group
Group type: COMPARATOR
Intervention: racemic-amphetamine
Number of subjects: 48
Study 1106966 — intervention group
Group type: EXPERIMENTAL
Intervention: dextro-amphetamine and racemic-amphetamine
Number of subjects: 48
Study 31461581 — intervention group
Group type: EXPERIMENTAL
Intervention: 14 days of twice‐daily 16.5% Manuka honey + 1.3 mg/mL methylglyoxal sinonasal rinses and concurrent 10 days of placebo tablets (MH)
Number of subjects: 25
Study 31461581 — intervention group
Group type: COMPARATOR
Intervention: 14 days of twice‐daily saline sinonasal rinses and concurrent 10 days of culture‐directed antibiotic therapy (CON)
Number of subjects: 25
Study 31461581 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety observations including the University of Pennsylvania Smell Identification Test (UPSIT)
Number of subjects: 25
Study 31461581 — intervention group
Group type: EXPERIMENTAL
Intervention: Efficacy assessed using Lund‐Kennedy scores (LKSs), visual analog scale (VAS), and 22‐item Sino‐Nasal Outcome Test (SNOT‐22)
Number of subjects: 25
Study 28886163 — intervention group
Group type: EXPERIMENTAL
Intervention: Bespoke mental health training package
Number of subjects: 249
Study 28886163 — intervention group
Group type: COMPARATOR
Intervention: Routine training
Number of subjects: 249
Study 25599305 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal clonidine, 100 μg
Number of subjects: 22
Study 25599305 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal adenosine, 2 mg
Number of subjects: 22
Study 25599305 — intervention group
Group type: COMPARATOR
Intervention: Both treatments (clonidine and adenosine)
Number of subjects: 22
Study 23910171 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of labour (N=321)
Number of subjects: 650
Study 23910171 — intervention group
Group type: COMPARATOR
Intervention: Expectant management (N=329)
Number of subjects: 650
Study 21152931 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous exercise (CONT)
Number of subjects: 11
Study 21152931 — intervention group
Group type: COMPARATOR
Intervention: Interval exercise (INT)
Number of subjects: 11
Study 21152931 — intervention group
Group type: COMPARATOR
Intervention: Recovery (REC)
Number of subjects: 11
Study 21152931 — intervention group
Group type: COMPARATOR
Intervention: Stroop Color Word Test (SCWT)
Number of subjects: 11
Study 20029100 — intervention group
Group type: EXPERIMENTAL
Intervention: SAQ training
Number of subjects: 20
Study 16978994 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invasive treatment strategy based on risk stratification
Number of subjects: 0
Study 16978994 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional centers of excellence for care of patients with acute ischemic heart disease
Number of subjects: 0
Study 12629445 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan therapy
Number of subjects: 1513
Study 12629445 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1513
Study 11003427 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection technique
Number of subjects: 50
Study 11003427 — intervention group
Group type: COMPARATOR
Intervention: Implantation technique
Number of subjects: 50
Study 9323618 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed umbilical cord clamping (30 seconds after birth)
Number of subjects: 46
Study 9323618 — intervention group
Group type: COMPARATOR
Intervention: Immediate umbilical cord clamping
Number of subjects: 46
Study 8259718 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil fatty acids supplementation
Number of subjects: 0
Study 8259718 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetarian diet
Number of subjects: 0
Study 8259718 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-vegetarians)
Number of subjects: 0
Study 3002786 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.1 mg kg‐1 and atropine 0.2‐0.4 mg i.m.
Number of subjects: 16
Study 3002786 — intervention group
Group type: COMPARATOR
Intervention: Papaveretum 0.4 mg kg‐1 and hyoscine 0.008 mg kg‐1 i.m.
Number of subjects: 16
Study 31274718 — intervention group
Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 88
Study 31274718 — intervention group
Group type: COMPARATOR
Intervention: Regional Anesthesia (RA)
Number of subjects: 88
Study 29017017 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster sets (CRT; n = 10)
Number of subjects: 30
Study 29017017 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional sets (TRT; n = 10)
Number of subjects: 30
Study 29017017 — intervention group
Group type: COMPARATOR
Intervention: Control (CON; n = 10)
Number of subjects: 30
Study 26850709 — intervention group
Group type: EXPERIMENTAL
Intervention: Bionic pancreas
Number of subjects: 19
Study 26850709 — intervention group
Group type: COMPARATOR
Intervention: Control (conventional insulin pump therapy)
Number of subjects: 19
Study 25285831 — intervention group
Group type: EXPERIMENTAL
Intervention: Contractor safety climate
Number of subjects: 1725
Study 25285831 — intervention group
Group type: EXPERIMENTAL
Intervention: Coworker safety climate
Number of subjects: 1725
Study 21865211 — intervention group
Group type: EXPERIMENTAL
Intervention: Natalizumab treatment (monotherapy in AFFIRM)
Number of subjects: 2
Study 21865211 — intervention group
Group type: EXPERIMENTAL
Intervention: Natalizumab treatment (in combination with interferon β‐1a in SENTINEL)
Number of subjects: 2
Study 21865211 — intervention group
Group type: EXPERIMENTAL
Intervention: Natalizumab treatment (both alone and in combination with IFNβ)
Number of subjects: 2
Study 20345732 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (TU, Nebido(®)), 1,000 mg injected on day 1, followed by injections after 6 weeks and 18 weeks
Number of subjects: 133
Study 20345732 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (TU, Nebido(®))
Number of subjects: 133
Study 18655991 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin instilled 4 times a day 1 day before surgery plus 1 drop 2 hours before surgery (Group A)
Number of subjects: 156
Study 18655991 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin instilled 2 hours before surgery and then every 15 minutes for 1 hour (Group B)
Number of subjects: 156
Study 18655991 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Group A and Group B
Number of subjects: 156
Study 11684917 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin, beta blockers, and angiotensin-converting enzyme inhibitors
Number of subjects: 1
Study 11684917 — intervention group
Group type: EXPERIMENTAL
Intervention: Reperfusion therapy (thrombolysis and primary angioplasty)
Number of subjects: 1
Study 9930483 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 17)
Number of subjects: 48
Study 9930483 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aprotinin (n = 15)
Number of subjects: 48
Study 9930483 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose aprotinin (n = 16)
Number of subjects: 48
Study 8040664 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine at a dose of 1,000 mg/m2
Number of subjects: 84
Study 8040664 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine at a dose of 1,250 mg/m2
Number of subjects: 84
Study 8040664 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Number of subjects: 84
Study 3051874 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin vaginal suppositories (PGE2)
Number of subjects: 30
Study 3051874 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study 30868734 — intervention group
Group type: EXPERIMENTAL
Intervention: DACC-coated dressing
Number of subjects: 144
Study 30868734 — intervention group
Group type: COMPARATOR
Intervention: Control dressing
Number of subjects: 144
Study 28974069 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (200 µg)
Number of subjects: 462
Study 28974069 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 462
Study 25928356 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation (ES)
Number of subjects: 40
Study 25928356 — intervention group
Group type: COMPARATOR
Intervention: Secondary intention wound healing (control)
Number of subjects: 40
Study 22699800 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA-PDT
Number of subjects: 64
Study 22699800 — intervention group
Group type: COMPARATOR
Intervention: Photofrin-PDT
Number of subjects: 64
Study 22699800 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ALA-PDT and Photofrin-PDT
Number of subjects: 64
Study 21806297 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 239
Study 21806297 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 239
Study 19170659 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surfactant treatment (31 +/- 19 min)
Number of subjects: 185
Study 19170659 — intervention group
Group type: COMPARATOR
Intervention: Late surfactant treatment (202 +/- 80 min)
Number of subjects: 185
Study 16708528 — intervention group
Group type: EXPERIMENTAL
Intervention: Impedance Threshold Device (ITD) during head-up tilt (HUT)
Number of subjects: 19
Study 16708528 — intervention group
Group type: COMPARATOR
Intervention: Sham control (no ITD) during head-up tilt (HUT)
Number of subjects: 19
Study 16708528 — intervention group
Group type: EXPERIMENTAL
Intervention: Impedance Threshold Device (ITD) in subgroup with < 20% reduction in SV
Number of subjects: 19
Study 15566454 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg elemental iron daily (n=55)
Number of subjects: 111
Study 15566454 — intervention group
Group type: COMPARATOR
Intervention: 200 mg elemental iron weekly (n=56)
Number of subjects: 111
Study 11220419 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed ventilation group
Number of subjects: 24
Study 11220419 — intervention group
Group type: COMPARATOR
Intervention: Constant CO2 group
Number of subjects: 24
Study 9283506 — intervention group
Group type: EXPERIMENTAL
Intervention: 65 mg of methadone
Number of subjects: 116
Study 9283506 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg of buprenorphine
Number of subjects: 116
Study 9283506 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of methadone
Number of subjects: 116
Study 9283506 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg of buprenorphine
Number of subjects: 116
Study 9283506 — intervention group
Group type: COMPARATOR
Intervention: Lower doses of buprenorphine and methadone
Number of subjects: 116
Study 9283506 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 116
Study 8285455 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperactive group (n = 39)
Number of subjects: 39
Study 8285455 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 39
Study 8285455 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed Hyperactive Group (DHG)
Number of subjects: 39
Study 8285455 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-Depressed Hyperactive Group (HG)
Number of subjects: 39
Study 8285455 — intervention group
Group type: EXPERIMENTAL
Intervention: HG group
Number of subjects: 39
Study 31808717 — intervention group
Group type: EXPERIMENTAL
Intervention: Incongruent text messages (mismatching regulatory focus)
Number of subjects: 279
Study 31808717 — intervention group
Group type: EXPERIMENTAL
Intervention: Congruent text messages (matching regulatory focus)
Number of subjects: 279
Study 31808717 — intervention group
Group type: COMPARATOR
Intervention: General health messages (control group)
Number of subjects: 279
Study 31176611 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (NAC)
Number of subjects: 66
Study 28942217 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 107
Study 28942217 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 107
Study 28942217 — intervention group
Group type: COMPARATOR
Intervention: Switching from olanzapine to risperidone
Number of subjects: 107
Study 28942217 — intervention group
Group type: COMPARATOR
Intervention: Risperidone and Olanzapine
Number of subjects: 107